Consolidated Balance Sheets - USD ($) $ in Millions		Sep. 30, 2025	Jun. 30, 2025
Current assets:
Cash and cash equivalents		$ 2,478.0	$ 3,347.8
Short-term marketable securities	[1]	5,466.1	4,498.8
Accounts receivable, net of allowance for doubtful accounts of $46.0 and $47.1, respectively		3,463.6	3,579.1
Other current assets		1,094.9	840.8
Total current assets before funds held for clients		12,502.6	12,266.5
Funds held for clients		31,699.9	30,985.7
Total current assets		44,202.5	43,252.2
Property, plant and equipment, net		646.7	655.4
Operating lease right-of-use asset		392.7	374.1
Deferred contract costs		3,120.8	3,154.1
Other assets		1,084.9	1,057.0
Goodwill		3,275.2	3,273.5
Intangible assets, net		1,598.0	1,603.0
Total assets		54,320.8	53,369.3
Current liabilities:
Accounts payable		129.0	169.1
Accrued expenses and other current liabilities		2,906.6	3,092.4
Accrued payroll and payroll-related expenses		601.9	973.1
Dividends payable		618.9	620.6
Short-term deferred revenues		258.1	262.8
Obligations under reverse repurchase agreements	[1]	247.4	38.4
Obligations under commercial paper borrowings		5,208.0	4,769.5
Income taxes payable		116.5	9.1
Total current liabilities before client funds obligations		10,086.4	9,935.0
Client funds obligations		31,845.6	31,343.3
Total current liabilities		41,932.0	41,278.3
Long-term debt		3,975.6	3,974.7
Operating lease liabilities		341.7	321.2
Other liabilities		1,041.4	1,058.3
Deferred income taxes		272.4	163.6
Long-term deferred revenues		383.9	385.2
Total liabilities		47,947.0	47,181.3
Commitments and contingencies (Note 14)
Stockholders' equity:
Preferred stock, $1.00 par value: authorized, 0.3 shares; issued, none		0.0	0.0
Common stock, $0.10 par value: authorized, 1,000.0 shares; issued, 638.7 shares at September 30, 2025 and June 30, 2025; outstanding, 404.9 and 405.3 shares at September 30, 2025 and June 30, 2025, respectively		63.9	63.9
Capital in excess of par value		2,868.0	2,788.3
Retained earnings		25,622.4	25,240.6
Treasury stock - at cost: 233.8 and 233.4 shares at September 30, 2025 and June 30, 2025, respectively		(21,449.8)	(21,021.4)
Accumulated other comprehensive loss		(730.7)	(883.4)
Total stockholders’ equity		6,373.8	6,188.0
Total liabilities and stockholders’ equity		$ 54,320.8	$ 53,369.3

[1] As of September 30, 2025, $247.4 million of short-term marketable securities have been pledged as collateral under the Company's reverse repurchase agreements. As of June 30, 2025, $38.4 million of short-term marketable securities have been pledged as collateral under the Company's reverse repurchase agreements (see Note 10).